The next meeting of the International Screening Network will be held in Turin, Italy, June 21-23, four years after the last meeting in 2019, will provide an opportunity to share lessons learned during the Covid-19 pandemic and to restart screening activities with new impetus and renewed energy. The event program will address several topics, from […]
In a study published in the journal Preventive Medicine, the team of professionals of the ICO-IDIBELL’s Colon Cancer Screening Unit has analyzed the short-term effects of COVID19 in the program in the areas of influence of the ICO: north and south metropolitan area. The program interrupted its activity for 5 months after the first wave […]
The course “Training for the accreditation of the professionals of the Endoscopic Units of the Colorectal Cancer Population Screening Program” has started. The first session of the course, organized by the technical office of screening of the Catalan Institute of Oncology, which covers the entire territory of the metropolitan area of Barcelona, was held on […]
A study led by the UCC has estimated the number of individuals at high risk of developing lung cancer in the different Spanish autonomous communities using a prediction model and selecting individuals with a 6-year risk of ≥2%. The main variable of the risk model is tobacco consumption calculated in pack-years. This measure takes into […]
The team of the Cancer Screening Unit together with researchers from the Biomarkers and Susceptibility Unit of the Institut Català d’Oncologia have demonstrated the benefit of participating in population screening for colorectal cancer with the fecal occult blood test in l’Hospitalet de Llobregat and l’Alt Penedès. This test allows to analyze if there is a […]
The project integrating genetic and clinical data to predict cancer risk, in which members of the UCC participate, has been selected for the second phase of the research call. In the fourth edition of the “La Caixa” Foundation’s call for projects in biomedicine and health (HR2021), 644 projects were presented in the following thematic areas: […]
According to a study prepared by researchers from the Cancer Screening Unit of the ICO l’Hospitalet and the EPIBELL Program (IDIBELL), in the period 2017-2018, out of a total of 643 pharmacies affiliated to the Official College of Pharmacists, 528 were adhered to the Program, a figure that corresponds to 85.4% of the total. Accessibility […]
Tumors missed by screening tests are known as interval cancers and are diagnosed after a negative screening episode result but before the next cancer screening program invitation. The Cancer Screening Unit team together with researchers from the Biomarkers and Susceptibility Unit of the Institut Català d’Oncologia have reviewed the current literature on interval colorectal cancer […]
The ICO Advisory Committee has been created with the aim of providing the General Directorate with permanent advice of proven solvency and sufficient specialization in the care of oncology patients and all users served by ICO in its different areas (prevention, care, research, and teaching). The Committee is made up of 20 professionals from different […]
The immunological fecal occult blood test (IFBT) is a non-invasive test that detects the presence of non-visible blood in the stool to locate polyps in the colon that could develop into a malignant tumor in time. However, it is not a perfect test and can give a false positive result (a positive TSOFi followed by […]
